WC3011 (Estradiol Vaginal Cream) for Vaginal Dryness in Postmenopausal Women

Phase 3, randomised, double-blind trial of estradiol topical in Vulvovaginal atrophy (VVA) (2 arms), sponsored by Warner Chilcott. Primary endpoints: Change From Baseline in Participant's Self-Assessment of Severity of Vaginal Dryness at 12 weeks, Change From Baseline in Vaginal pH at 12 weeks and 2 more. Started Jan 2013; status: completed.